CAS: 1384426-12-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-Propenethioamide, 3-(3-bromo-4,5-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]-, (2E)- REF: IN-DA00195NCAS: 1384426-12-3 | 98% | To inquire | Tue 07 Jan 25 |
 | NT157 REF: TM-T4605CAS: 1384426-12-3 | 97.55% | 54.00 €~807.00 € | Tue 14 Jan 25 |
 | NT-157 REF: 3D-FN137703CAS: 1384426-12-3 | Min. 95% | - - - | Discontinued product |
![2-Propenethioamide, 3-(3-bromo-4,5-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]-, (2E)-](https://static.cymitquimica.com/products/IN/thumb/DA00195N.jpg)
2-Propenethioamide, 3-(3-bromo-4,5-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]-, (2E)-
CAS:1384426-12-3
Formula:
C16H14BrNO5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
412.2551
Ref: IN-DA00195N
| 2mg | 155.00 € | ||
| 5mg | 230.00 € | ||
| 25mg | 643.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
NT157
CAS:1384426-12-3
NT157, a small tyrphostin, inhibits IRS, IGF-1R, and STAT3 in TME, reducing cancer cell survival.
Formula:
C16H14BrNO5S
Purity:
97.55%
Color and Shape:
Solid
Molecular weight:
412.26
Ref: TM-T4605
| 1mg | 54.00 € | ||
| 5mg | 125.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 361.00 € | ||
| 50mg | 569.00 € | ||
| 100mg | 807.00 € | ||
| 1mL*10mM (DMSO) | 140.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
NT-157
CAS:1384426-12-3
NT-157 is a small-molecule drug that targets the JAK2 V617F mutation found in chronic myeloid …
Purity:
Min. 95%
Ref: 3D-FN137703
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
